FLCCC Alliance Study to Determine Efficacy of Repurposed Drugs in Treating Cancer (2024)

By Dr. Frank Yap, MD -

A team of U.S. clinicians will participate in an observational study to determine improvements in the five-year survival rate for several types of cancer

WASHINGTON, D.C. – The FLCCC Alliance announced that it has partnered with renowned breast cancer physician and researcher Kathleen Ruddy, MD, to conduct an observational study in five U.S. clinics to track patient responses to various adjunct cancer therapies using repurposed drugs and determine improvements in the five-year survival rate to several types of cancer including breast, prostate, lung, and colorectal.

 

More people than ever will be diagnosed with cancer this year, according to the American Cancer Society. Conventional cancer treatments have succeeded in preventing more than 4 million deaths from cancer since 1991. However, emerging research continues to demonstrate that more can be done using treatment regimens that include well-studied repurposed drugs.

“We hope that our research will bring attention to often overlooked methods for treating cancer as well as managing the symptoms from conventional treatment,” said Paul E. Marik, M.D., FCCM, FCCP, lead author of the study, chief scientific officer of the FLCCC and former Chief, Pulmonary and Critical Care Medicine at Eastern Virginia Medical School. “Our research is intended to advance a better understanding of how cancer can be treated more efficiently, with fewer side effects, through using well-studied approaches that include readily available medications that are well-studied and known to have minimal side effects.”

The final study results will focus on improvements in the five-year survival rate of certain cancers and include patients from five clinics nationwide that will collaborate and share anonymous patient information in a centralized collection tool where the data will be tracked and analyzed.

“Cancer continues to increase at an alarming rate, especially among younger populations, creating an imminent public health crisis,” said Kathleen Ruddy, MD, founder of the New Jersey-based practice Breast Health and Healing. “For over a year, I have been observing and advising 50 patients using a variety of repurposed treatments in the regimen, with some having remarkable results. More is to be learned, so I am excited to partner with the FLCCC on this new research.”

FLCCC Observational Cancer Study: Participating Providers

1. Health and Healing: Kathleen T. Ruddy, MD

Dr. Ruddy is a retired cancer surgeon trained at Memorial Sloan-Kettering Cancer Center. During her 28 years in practice, she took care of more than 10,000 patients in the United States and abroad. She has a Masters degree in International Healthcare Leadership from McGill University. She served on the Leadership Council of the Harvard School of Public Health and was deeply involved in mobilizing international support for West Africa during the outbreak of Ebola in 2014. Dr. Ruddy authored the first book about the human breast cancer virus, The End of Breast Cancer: A Virus and the Hope for a Vaccine. She is now a scientific investigator in an observational study whose objective is to answer the question, "Do repurposed, FDA-approved drugs like ivermectin improve the survival of patients with cancer?"

Telemedicine Appointments Only. 

Contact:
  • Kathleenmrca@aol.com,
  • (201) 323-2288
Address: 46 Green Village Road, Madison, New Jersey 07940

2. Leading Edge Clinic

Pierre Kory, MD, MPA
Scott Marsland, FNP-C

The Leading Edge Clinic, led by Pierre Kory and Scott Marsland, offers specialized evaluation and individualized treatment plans for COVID-19, Long COVID, COVID vaccine injury syndromes, General medicine and Integrated conventional complementary cancer treatment via telehealth. Our care is based on deep scientific study, national and global clinical practice experience, and compassion to meet the whole-person needs of patients.

Telemedicine Appointments Only. 

Contact: 
  • Tisha Palmer, Practice Manager 
  • practicemanager@drpierrekory.com 
  • Register as a patient and fill out intake forms at New tab 
  • https://drpierrekory.com/ 
  • (608) 400-0141 
Address: 213 Tioga St, #6834, Ithaca, New York 14851-9997

3. The James Clinic: Mollie James, DO, MPH, FACOS FACS, IFMCP

Dr. James is board certified in general surgery and critical care medicine. She trained at Mercy Medical Center-Des Moines and the University of Minnesota. After practicing for five years, she realized she needed additional tools to help her patients. Functional medicine was the answer. She combined functional medicine into her surgery practice for patients with GI issues presenting for endoscopy and it had immediate benefit to patients. The James Clinic was launched to fulfill the unmet needs of patients, which became even more obvious during 2020. Providing convenient, accessible care and a direct physician-patient relationship without conflicts of interest. 

In-person & Telemedicine Appointments. 

Contact: 
  • hello@jamesclinic.com 
  • https://jamesclinic.com/request-a-consult 
  • (636) 751-9440 
Address: 934 North 7th Street, Chariton, Iowa 50049
States: AR, IA, IL, KY, MI, MO, NC, OK


More information about the Study: https://covid19criticalcare.com/cancer-study/

Dr. Paul Marik, the most published Critical Care Specialist in the United States, has tackled Cancer. Dr. Marik reviewed thousands of studies, and in the process, uncovered fundamental truths and busted persistent myths in publishing Cancer Care 1st Edition. The 2nd edition expands these and adds propranolol, a relatively unknown anticancer agent. Moreover, ivermectin is moved up to Tier One based on emerging evidence. 

The FLCCC Alliance published its Cancer Care Monograph 1st edition in June 2023 and 2nd edition in October 2024. A copy of the 2nd edition monograph can be found here: https://covid19criticalcare.com/reviews-and-monographs/cancer-care/.

About the FLCCC Alliance

The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned critical care physicians and scholars with the academic support of allied physicians from around the world. FLCCC’s goal is to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness including the I-RECOVER protocols for “Long COVID” and Post Vaccine Syndrome. For more information: www.FLCCC.net

Related: 

Comments

Post a Comment

Labels

Show more

Archive

Show more

Popular posts from this blog

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2024)

By Dr. Frank Yap, MD -
Image
If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories. We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these different cancers in the mice. The scientist was later diagnosed with s...
Read more

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

By Dr. Frank Yap, MD -
Image
Ivermectin Resources Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. I have two articles and a Video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose IVERMECTIN and CANCER 2024 - NEW STUDIES 2024 Baghli et al - Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024. Co-authors include Dr Paul Marik and Dr William Makis. 2024 Fan et al  - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage ( 2024 Man-Yuan Li et al ) - Ivermectin induces non-protective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells ( 2024 Kaur et al ) - Ivermectin: A Multifaceted drug with a potential beyond anti-parasitic therapy ( 2024 Xing Hu et ...
Read more

Fenbendazole Cancer Success Stories: Case Series Compilation (December 2024 Edition)

By Dr. Frank Yap, MD -
Image
Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories (5 cases) Bladder Cancer Success Stories (2 cases) Cervical Cancer Colorectal Cancer (7 cases) Esophageal and Stomach cancer Fatty Tumour Gastric (Stomach) cancer (2 cases) Glioblastoma (Brain Cancer) Head and Neck Cancer Kidney Cancer Case Series (7 cases) Liver Cancer (2 cases) Lung Cancer (8 cases) Lymphoma (2 cases) Multiple Myeloma Oral Cancer Ovarian Cancer Pancreatic Cancer (8 cases) Prostate Cancer (8 cases) Sarcoma (2 cases) Squamous Cell Carcinoma Skin Cancer (4 cases) Throat Cancer Thymus cancer Turbo Cancer Uterine cancer Editor's Preface Before you continue to read this long-form article, let's start with the end in mind and begin with the conclusion that you may have been told from various mainstream media channels or your conventional cancer specialists: We shall wait for bigger and better quality evidence before we can make fo...
Read more

Top Oncologist Blows Whistle: ‘Ivermectin Proven More Effective Than Chemotherapy’

By Dr. Frank Yap, MD -
Image
Ivermectin has proven more effective than chemotherapy, without any of the debilitating side-effects, according to world-renowned Canadian oncologist Dr. William Makis who cited a major international cancer study to make his case. Dr. Makis asserts that the study’s findings call for a profound shift in the treatment of advanced breast cancer, as the evidence shows Ivermectin could significantly outperform traditional chemotherapy. According to Dr. Makis, the anti-parasitic drug Ivermectin has shown staggering results, outperforming the widely-used chemotherapy drug Paclitaxel and destroying cancer stem cells — those responsible for metastasis and recurrence. Dr. Makis based his urgent plea on a 2017 study by Mexican researchers, which should have fundamentally changed breast cancer treatment. Published as “Ivermectin as an Inhibitor of Cancer Stem Cells,” the study reveals how Ivermectin annihilates breast cancer stem cells, offering new hope for patients battling advanced stag...
Read more

Fenbendazole: Questions Answered, Things to Know, Useful Tips - Ben Fen

By Dr. Frank Yap, MD -
Image
Readers ask a variety of questions regarding the use of fenbendazole. This article is mainly a result of those questions and has been in the hopper for quite a while. It is long overdue as it contains items of importance that, if we waited for the appropriate thematic venue to publish them, they might never see the light of day. With that in mind, please accept the following for what it is: a hodgepodge of fenbendazole-related items that are very important to know. Incorporate these bits and pieces into your arsenal of ideas regarding fenbendazole, any unique insights that come to mind please feel free to share. How Safe is Fenbendazole? Is fenbendazole harmful to humans? Due to the long and successful use of fenbendazole as a veterinary antiparasitic medicine since the late 1950s, a wealth of safety data has been acquired that has stood the test of time. According to Drugs.com, there are no commonly used drugs that interact with fenbendazole. Fenbendazole is so safe for veterinary con...
Read more

12 Types of Zinc Supplementation and Absorption 2024

By Dr. Frank Yap, MD -
Image
Zinc is a powerful immune nutrient known for its benefits for providing immune health support and anti inflammation as well as for improving cold and respiratory symptoms, wound healing, acne reduction, and lowering the risk of age-related diseases. Research on atherosclerosis and diabetes mellitus suggests that zinc deficiency may contribute to low-grade systemic inflammation. Types of Zinc What's the best absorbed zinc supplement form?  We know there’s an ocean of information out there to navigate, so we’ve compiled a list of common zinc types and an overview on each zinc type below. There are several types of zinc supplements. Supplements contain several forms of zinc, including zinc gluconate, zinc citrate and zinc picolinate. The percentage of elemental zinc varies by form.  Choosing a zinc supplement can be confusing because there are so many different types. zinc acetate zinc an...
Read more

FENBENDAZOLE in Stage 4 Cancers - the 2021 Stanford University Case Series

By Dr. Frank Yap, MD -
Image
What is the "Stanford Fenbendazole Protocol"? I bet you've never heard of the "Stanford Fenbendazole Protocol" for treating Cancer. Yet, it exists. But it's heavily suppressed by search engines and mainstream Oncology, especially in the United States and Canada. In 2021 a group at Stanford University Medical Center, Department of Medicine, published a Case Series (Clin. Oncol. Case Rep 2021)* on a "forbidden" repurposed drug, Fenbendazole. *Note: Clinical Oncology Case Reports is a peer-reviewed International clinical and medical oncology and cancer research Journal. Clinical Oncology Case Reports (COCR) is a high-impact multidisciplinary journal focus on the area of clinical and medical investigation. They wrote about 3 cases of Stage 4 Cancer patients who self-treated and cured their cancers.   Case 1: 63 year old man with a Stage 4 Renal Cell Carcinoma (clear cell) , a 5.3cm mass and mets to pancreas and bone, failed 3 lines of chemo. He ac...
Read more

FENBENDAZOLE and CANCER: "15 Minutes with Dr. William Makis"

By Dr. Frank Yap, MD -
Image
Transcription (emphasis 2SG - 2nd Smartest Guy):  Hi, everyone. Welcome to another episode of 15 minutes with Dr. Makis, my new hard hitting medical podcast. This episode is about  fenbendazole  and cancer.  I will give you the most comprehensive review of the use of  fenbendazole  in cancer there is.   Fenbendazole  is an antiparasitic.  It is a dog dewormer, has been used It's been used as an antiparasitic since the 1960s,   and it has been shown to have extensive anti cancer activity.    Now, it's not FDA approved for use in humans. There is a version of it that is almost identical that is approved for use in humans by the FDA, and it's called mebendazole. (2SG: Mebendazole is BigPharma’s money grab whereby they removed a molecule from fenbendazole such that they could egregiously up-charge for a slightly inferior compound based on a bogus patent). I will do a separate video for mebendazole because the...
Read more

Fenbendazole for Humans: Safety and Efficacy Examined (2024)

By Dr. Frank Yap, MD -
Image
Fenbendazole is a broad spectrum anthelmintic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. ( Wikipedia )  Fenbendazole, has garnered ⁤attention​ for its potential use ​in‍ humans.‍ The Fenbendazole Cancer Protocol gained rapid interest over the past years following some fenbendazole advanced cancer success stories . Joe Tippens founded the protocol  after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The ...
Read more

Is a combination of Fenbendazole and Ivermectin a real cancer killer?

By Dr. Frank Yap, MD -
Image
Fenbendazole and/or Mebendazole seem the perfect pairing with Ivermectin as an off label combination against cancer; recent research shows this 3-in-1 combination attacks the mitochondrial stem cell connection. I am increasingly asked by cancer patients about the combination of anthelmintic Fenbendazole and Ivermectin against cancer. Importantly, these patients aren’t the usual stage 2 cancer patients for whom conventional medicine still has a long way to go. These belong to two distinct groups. First, there are older men whose lung cancer or prostate cancer has returned and they feel that conventional medicine (which they had before) didn’t work before, so why would it work next time. They subscribe to Einstein’s definition of insanity - doing the same thing over and over again and expecting a different result. Secondly, and this is an equally big group of patients - under 40s with rampant breast cancer, colorectal cancer or lymphoma - the 'early onset' cancer victims. Yes, I ...
Read more